Reuters: Health
Biogen Inc and Eisai Co Ltd are abandoning two late-stage trials for their Alzheimer's treatment in a widely anticipated move that comes months after the companies scrapped trials of another drug for the memory-robbing disease.
Biogen scraps two late-stage trials for Alzheimer's treatment
Biogen scraps two late-stage trials for Alzheimer's treatment
Reuters: Health
Biogen Inc and Eisai Co Ltd are abandoning two late-stage trials for their Alzheimer's treatment in a widely anticipated move that comes months after the companies scrapped trials of another drug for the memory-robbing disease.
Reuters: Health
Biogen Inc and Eisai Co Ltd are abandoning two late-stage trials for their Alzheimer's treatment in a widely anticipated move that comes months after the companies scrapped trials of another drug for the memory-robbing disease.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment